Cingulate

Cingulate Market Cap per Employee

The Market Cap per Employee of Cingulate (CING) as of Nov 11, 2026 is 5.48 M USD. In the previous year, Market Cap per Employee was 5.48 M USD — a change of 0.00% (lower).

Market Cap per Employee

5.48 MUSD

YoY

0.00%

Last updated:

Market Cap per Employee of Cingulate is 2025 5.48 M USD. Market Cap per Employee of Cingulate was 2024 5.48 M USD. It decreases by 0.00% lower compared to the previous year.

The Cingulate Market Cap per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market Cap per Employee
Date
Market Cap per Employee
Jan 1, 2019
5.48 M USD
Jan 1, 2020
5.48 M USD
Jan 1, 2021
5.48 M USD
Jan 1, 2022
5.48 M USD
Jan 1, 2023
5.48 M USD
Jan 1, 2024
5.48 M USD
Jan 1, 2025
5.48 M USD
The Cingulate Market Cap per Employee history
YEARMarket Cap per EmployeeYoY
5.48 MUSD0.00%
5.48 MUSD0.00%
5.48 MUSD0.00%
5.48 MUSD0.00%
5.48 MUSD0.00%
5.48 MUSD0.00%
5.48 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cingulate Stock analysis

What does Cingulate do? Cingulate Inc is a US-based biopharmaceutical company headquartered in Kansas City, Kansas, that focuses on the development, manufacturing, and commercialization of pharmaceutical products. The firm utilizes its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles designed to improve the lives of patients suffering from commonly diagnosed conditions. The company specifically targets the treatment of attention deficit/hyperactivity disorder (ADHD) through its innovative approach to drug delivery. The firm is currently developing two lead product candidates, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). These drug candidates both contain three releases of an active pharmaceutical ingredient combined into one small tablet dosage form. By employing this technology, Cingulate Inc aims to provide effective treatment options for ADHD across three core patient segments: children aged 6-12, adolescents aged 13-17, and adults aged 18 and older. Cingulate is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cingulate stock

Market Cap per Employee of Cingulate is 5.48 M USD in 2025.

Market Cap per Employee of Cingulate changed from 5.48 M USD to 5.48 M USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Market Cap per Employee Cingulate since 2006 – with annual values, charts, and detailed analysis.

Market cap per employee shows the market value attributed to each employee. Technology companies typically have higher values due to intellectual capital.

Market Cap per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Market Cap per Employee's Cingulate historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Cingulate

All Key Metrics — Cingulate